Drug profile · INN
vincristine sulfate
VINCRISTINE SULFATE
vincristine sulfate (VINCRISTINE SULFATE) is a tubulin inhibitor. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
Drug details — vincristine sulfate
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 20
- Data quality
- 0.89
Quick answer
vincristine sulfate (VINCRISTINE SULFATE) is a tubulin inhibitor. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Tubulin inhibitor
Primary target: Tubulin
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is vincristine sulfate?
vincristine sulfate (VINCRISTINE SULFATE) is a tubulin inhibitor. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for vincristine sulfate?
VINCRISTINE SULFATE is a marketed brand name for vincristine sulfate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of vincristine sulfate?
vincristine sulfate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.